Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis

Journal of Hepatology

Volumn 63, Issue 5, 2015, Pages 1212-1219

  De Vries, Elisabeth M G ^a   Verheij, Joanne ^a   Hubscher, Stefan G ^b   Leeflang, Mariska M G ^a   Boonstra, Kirsten ^a   Beuers, Ulrich ^a   Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; COHORT ANALYSIS; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; ISHAK SYSTEM; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LUDWIG SYSTEM; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAKANUMA SYSTEM; OUTCOME ASSESSMENT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SCORING SYSTEM; STAGING; SURVIVAL; TIME TO TREATMENT; TRANSPLANT FREE SURVIVAL; BIOPSY; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIOLOGY; LIVER; METABOLISM; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTOR; TRENDS;

BIOMARKERS; BIOPSY; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 84945439008     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.06.008     Document Type: Article

References (34)

1. G.M. Hirschfield, T.H. Karlsen, K.D. Lindor, and D.H. Adams Primary sclerosing cholangitis Lancet 382 2013 1587 1599
2. D. Maneesh, B.J. Elmunzer, B. Dwamena, and P. Higgins Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography Radiology 256 2010 387 396
3. C. Weber, R. Kuhlencordt, R. Grotelueschen, U. Wedegaertner, T.L. Ang, G. Adam, and et al. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis Endoscopy 40 2008 739 745
4. R. Maccarty, N. Larusso, R. Wiesner, and J. Ludwig Primary sclerosing cholangitis: findings on cholangiography and pancreatography Radiology 149 1983 39 44
5. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, B. Shneider, and et al. Diagnosis and management of primary sclerosing cholangitis. AASLD Practice Guidelines Hepatology 51 2010 660 678
6. EASL EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
7. K.D. Lindor Ursodiol for primary sclerosing cholangitis N Engl J Med 336 1997 691 695
8. K.D. Lindor, K.V. Kowdley, V.A. Luketic, M.E. Harrison, T. McCashland, A.S. Befeler, and et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
9. S.A. Mitchell, D.S. Bansi, N. Hunt, K. Von Bergmann, K.A. Fleming, and R.W. Chapman A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis Gastroenterology 121 2001 900 907
10. M. Färkkilä, A.-L. Karvonen, H. Nurmi, H. Nuutinen, M. Taavitsainen, P. Pikkarainen, and et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial Hepatology 40 2004 1379 1386
11. D.W. Hommes, W. Erkelens, C. Ponsioen, P. Stokkers, E. Rauws, M. van der Spek, and et al. A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis J Clin Gastroenterol 42 2008 522 526
12. D.H. Van Thiel, P. Carroll, K. Abu-elmagd, W. Irish, M. Sc, J. Mcmichael, and et al. Tacrolimus (FK), a treatment for primary sclerosing cholangitis; results of an open-label preliminary trial Am J Gastroenterol 90 2010 455 459
13. P. Angulo, K.P. Batts, R.A. Jorgensen, N.A. LaRusso, and K.D. Lindor Oral budesonide in the treatment of primary sclerosing cholangitis Am J Gastroenterol 95 2000 2333 2337
14. C. Barbatis, P. Grases, H. Sheperd, R. Chapman, J. Trowlell, D.P.J. Jewell, and et al. Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis J Clin Pathol 38 1985 778 783
15. P. Scheuer, and F. Path Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Ludwig symposium on biliary disorders-part II Mayo Clin Proc 73 1998 179 183
16. Z.D. Goodman Grading and staging systems for inflammation and fibrosis in chronic liver diseases J Hepatol 47 2007 598 607
17. J. Ludwig, E. Dickson, and G. McDonald Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch 22 1978 103 112
18. K. Boonstra, R.K. Weersma, K.J. van Erpecum, E.A. Rauws, B.W.M. Spanier, A.C. Poen, and et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Hepatology 58 2013 2045 2055
19. B. Portmann, and Y. Zen Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation Histopathology 60 2012 236 248
20. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, and et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
21. Y. Nakanuma, Y. Zen, K. Hararda, and M. Sasaki Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement Pathol Int 60 2010 167 174
22. K. Hiramatsu, H. Aoyama, Y. Zen, and S. Aishima Proposal of a new staging and grading system of the liver for primary biliary cirrhosis Histopathology 49 2006 466 478
23. E.M. Hennes, M. Zeniya, A.J. Czaja, A. Parés, G.N. Dalekos, E.L. Krawitt, and et al. Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176
24. Y. Kakuda, K. Hararda, S. Sawada-Kitamura, H. Ikeda, and Y. Nakanuma Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems Hum Pathol 44 2013 1109 1117
25. T. Kumagi, M. Guindi, S.E. Fischer, T. Arenovich, R. Abdalian, C. Coltescu, and et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis Am J Gastroenterol 105 2010 2186 2194
26. A. Ruiz, S. Lemoinne, F. Carrat, C. Corpechot, O. Chazouillères, and L. Arrivé Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression Hepatology 59 2014 242 250
27. A.W.H. Chan, R.C.K. Chan, G.L.H. Wong, V.W.S. Wong, P.C.L. Choi, H.L.Y. Chan, and et al. Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication Histopathology 65 2014 174 186
28. T. Queen, K. Cox, and D.G. Adler Primary sclerosing cholangitis in the setting of normal liver chemistries can be associated with severe ductal disease and dominant strictures Dig Dis Sci 2014 229 230
29. R. Olsson, I. Hägerstrand, U. Broomé, A. Danielsson, G. Järnerot, L. Lööf, and et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis J Clin Pathol 48 1995 933 935
30. P. Angulo, D.R. Larson, T.M. Therneau, N.F. LaRusso, K.P. Batts, and K.D. Lindor Time course of histological progression in primary sclerosing cholangitis Am J Gastroenterol 94 1999 3310 3313
31. T. Kawada The appropriate number of endpoints to keep validity for Cox proportional hazard analysis Int J Cardiol 153 2011 110 111
32. J. Concato, P. Peduzzi, T.R. Holford, and A.R. Feinstein Importance of events per independent variable in proportional hazards analysis I. Background, goals, and general strategy J Clin Epidemiol 48 1995 1495 1501
33. P. Peduzzi, J. Concato, A.R. Feinstein, and T. Holford Importance of eventers per independent variable in proportional hazard regression analysis II. Accuracy and precision of regression estimates J Clin Epidemiol 48 1995 1503 1510
34. M. Guido, and M. Rugge Liver biopsy sampling in chronic viral hepatitis Semin Liver Dis 24 2004 89 97